Laparoscopy

Canada Laparoscopy Devices Market Report 2022: Analysis and Forecasts 2021-2031 - Rising Regulatory Approvals for Robotic Systems - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 22, 2022
Surgery, Health, Medical Devices, Medtronic, Health Canada, Scholly, COVID-19, Risk, Johnson & Johnson, Acquisition, Growth, Benchmarking, Intuitive Surgical, Laparoscopy, Ethicon Inc., Robotics, General surgery, Hugo, Medical device, Animal, Pharmaceutical industry, Dentistry

The "Canada Laparoscopy Devices Market: Focus on Product, Application, and End User - Analysis and Forecast, 2022-2031" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Canada Laparoscopy Devices Market: Focus on Product, Application, and End User - Analysis and Forecast, 2022-2031" report has been added to ResearchAndMarkets.com's offering.
  • The COVID-19 pandemic has impacted practically all sectors and social functions worldwide, including the Canada laparoscopy devices market.
  • COVID-19 led to a decline in the Canada laparoscopy devices market, as elective and surgical procedures were stopped during the lockdown.
  • The conventional laparoscopy devices segment holds the larger share in the Canada laparoscopy devices market at $350.6 million compared to the robotic-assisted laparoscopy devices segment which is valued at $41.5 million in the year 2021.

KARL STORZ Receives Innovative Technology Designation from Vizient for TIPCAM1 Rubina with ARTip SOLO Robotic Assistance

Retrieved on: 
Friday, December 23, 2022
Oncology, Software, Medical Devices, Hardware, Hospitals, Data Management, Technology, Practice Management, Veterinary, Nursing, Managed Care, Medical Supplies, Cardiology, General Health, Surgery, Robotics, Health, Health Technology, Surgeon, Patient safety, Karl Storz SE, The Chartered Institute of Ergonomics and Human Factors, ONE, Environment, The Queen's Award for Enterprise: Innovation (Technology) (2011), Artipic, Robotics, Academic health science centre, Safety, MD, Health, Multimedia, KARL, Laparoscopy, 3D, Workflow, Hospital, Zenith Contract Services, Pharmaceutical industry, Medical imaging, Medicine, Medical device, Vizient, Inc., Oncology, Software, Medical Devices, Hardware, Hospitals, Data Management, Technology, Practice Management, Veterinary, Nursing, Managed Care, Medical Supplies, Cardiology, General Health, Surgery, Robotics, Health, Health Technology

KARL STORZ Endoscopy-America, Inc., proudly announces its TIPCAM®1 Rubina® with ARTip® SOLO robotic assistance has received an Innovative Technology designation from Vizient, Inc. , the largest healthcare performance improvement company in the country.

Key Points: 
  • KARL STORZ Endoscopy-America, Inc., proudly announces its TIPCAM®1 Rubina® with ARTip® SOLO robotic assistance has received an Innovative Technology designation from Vizient, Inc. , the largest healthcare performance improvement company in the country.
  • KARL STORZ exhibited TIPCAM1 Rubina with ARTip SOLO at the Vizient Innovative Technology Exchange on Oct. 17 in Dallas, Texas.
  • The ARTip® SOLO robotic camera guidance system allows the operating surgeon to maintain stability and precise control of the field of view.
  • Congratulations to KARL STORZ.”
    For more detailed information, about TIPCAM®1 Rubina® and ARTip® SOLO technology, visit karlstorznetwork1.com .

Olympus to Join Government Project to Verify Dissemination of Endoscopic AI Diagnosis in Vietnam

Retrieved on: 
Tuesday, December 6, 2022
Woman, MIC, Communication, Physician, Colorectal cancer, Diagnosis, Quality of life, Laparoscopy, Olympus, Health, Research, Ministry, Partnership, Hospital, Internal affairs, Sale, Cancer, GI, SDG, Endoscopy, Disease, International expansion of Netflix, AI, Cho Ray Hospital, Patient, Medical device

from Cho Ray Hospital said, "AI is a new and powerful technology making endoscpic procedure more efficient and high quality.

Key Points: 
  • from Cho Ray Hospital said, "AI is a new and powerful technology making endoscpic procedure more efficient and high quality.
  • Olympus has joined this project to support the specialists training doctors in Vietnam, to verify the effectiveness and dissemination of AI-assisted colonoscopy, and to contribute to the development of the healthcare environment in Vietnam.
  • This project aims to contribute to the introduction and dissemination of Japan's endoscopic AI diagnostic support system to Vietnam in response to the social issue of increasing cancer prevalence in Vietnam.
  • Research will be conducted on the effectiveness and future use of the AI diagnosis support system at Cho Ray Hospital and 108 Hospital in Vietnam.

Olympus Announces Launch of Olympus Asia Pacific Innovation Program

Retrieved on: 
Monday, December 5, 2022
Breast cancer, Quality of life, Management of prostate cancer, Laparoscopy, Health, Incidence, Colon, Medicine, Endoscopy, Lung, Stomach, Growth, Cancer, Military Medical Business, Automotive Supplier Innovation Program, Patient, Medtech, Medical imaging, Pharmaceutical industry, Online shopping, Dentistry, Medical device

As part of Olympus' dedication to continuing its history of innovation, Olympus is proud to announce the inaugural Olympus Asia Pacific Innovation Program (OAIP).

Key Points: 
  • As part of Olympus' dedication to continuing its history of innovation, Olympus is proud to announce the inaugural Olympus Asia Pacific Innovation Program (OAIP).
  • Olympus believes that the emergence of new technologies, particularly those within the digital realm, will revolutionize the patient care paradigm.
  • Felicia Chung, Olympus Business Development Leader for the Asia Pacific region said "I am pleased to announce Olympus' first-ever Innovation Program that seeks to identify and collaborate with innovators in the very exciting medtech space.
  • Marc Radatt, CEO for Olympus Corporation of Asia Pacific Limited and board member of the Asia Pacific Medical Technology Association (APACMed), said "Olympus is proud to have partnered with MedTech Innovator Asia Pacific in pursuit of new ideas that will revolutionize patient outcomes and increase access to new technologies through the OAIP.

Kalos Medical Announces Promotion of Seokjoo Chang, Ph.D. to Co-Chief Executive Officer

Retrieved on: 
Tuesday, December 6, 2022
Electricity, Paralysis, Checkmate, Seoul National University, Biomedical engineering, Pivotal, Case Western Reserve University, MS, Hypertension, Biotechnology, Moyamoya disease, Catholic University of Korea, University of Washington Department of Bioengineering, Randomized controlled trial, Union, Department of Electrical Engineering and Information Technology of TU Darmstadt, Catholic higher education, Growth, BS, Research, Investment, Electrode, University, Laparoscopy, Patient, Management, Pharmaceutical industry, EU

LOS ANGELES and SEOUL, South Korea, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Kalos Medical (“Kalos”), the developer of advanced medical devices treating hypertension and cardiovascular conditions, today announced the promotion of Seokjoo Chang, Ph.D., to Co-Chief Executive Officer, a position he will share with current CEO and Chairman Dr. Chuljoon Kim.

Key Points: 
  • LOS ANGELES and SEOUL, South Korea, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Kalos Medical (“Kalos”), the developer of advanced medical devices treating hypertension and cardiovascular conditions, today announced the promotion of Seokjoo Chang, Ph.D., to Co-Chief Executive Officer, a position he will share with current CEO and Chairman Dr. Chuljoon Kim.
  • Dr. Chang joined Kalos in May 2022 as President and Chief Technology Officer.
  • “I am honored to accept this new role as Co-Chief Executive Officer of Kalos,” Dr. Chang commented.
  • Checkmate Capital's primary areas of investment are biotechnology, life sciences, medical technology, agriculture technology, energy technology, and other diversified technologies.

Global Medical Robotic Systems Market Report (2022-2027): Increasing Government Initiatives for Improving Awareness About Diagnosis and Treatment Drive Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 15, 2022
Practice Management, Technology, Health, Radiology, Robotics, Health Technology, Medical Devices, Infectious Diseases, Apps, Applications, Surgery, COVID-19, Observation, Porter's five forces analysis, Others, Cobalt therapy, Sofie (surgical robot), Ansoff Matrix, Robotics, Robot-assisted surgery, Physical therapy, Neurology, COVID-19, Degenerative disease, Vision Guided Robotic Systems, SWOT, USD, Growth, Investment, Risk, Neglected tropical disease research and development, Market development, Orthopedic surgery, Medical device, Retail, Risk management, Pharmaceutical industry, Cancer, Hospital, Laparoscopy, Geography

Growing Incidences of Diseases Such as Cancer, Neurological Disorders, Orthopedic Surgery, and Cardiovascular Diseases

Key Points: 
  • Growing Incidences of Diseases Such as Cancer, Neurological Disorders, Orthopedic Surgery, and Cardiovascular Diseases
    The Global Medical Robotic Systems Market is segmented based on Type, Applications, and Geography.
  • By Type, the market is classified into Assistive and Rehabilitation Systems, Non-invasive Radiosurgery Robotic Systems, Non-medical Robotics in Hospitals, Prosthetics/Exoskeletons, and Surgical Robots.
  • The report presents a detailed Ansoff matrix analysis for the Global Medical Robotic Systems Market.
  • The report offers a comprehensive evaluation of the Global Medical Robotic Systems Market.

New View Surgical Announces First Commercial Case of the VisionPort™ System, Performed by David Earle, M.D., F.A.C.S.

Retrieved on: 
Tuesday, December 6, 2022
Surgery, Health, Medical Devices, Learning, Paola Lattus, MIS, Gallbladder, Laparoscopy, FDA, Lowell General Hospital, Tufts University School of Medicine, Hospital, Medical device

The VisionPort system is a revolutionary product for laparoscopy that addresses many unmet needs in the operating room, shared Dr. Earle.

Key Points: 
  • The VisionPort system is a revolutionary product for laparoscopy that addresses many unmet needs in the operating room, shared Dr. Earle.
  • I believe that the VisionPort will not only change how surgeons think about performing minimally invasive surgery but will enhance laparoscopy in both academic and austere environments.
  • The New View Surgical team is excited to embark on this next step in our journey, stated Bryce Klontz, New View Surgical President and CEO.
  • New View Surgical is an emerging medical device company focused on the development and commercialization of the VisionPort System, a novel surgical imaging and access system for minimally invasive surgery.

Olympus Announces EMEA Expansion of Exclusive Partnership with EndoClot Plus, Inc.

Retrieved on: 
Thursday, December 8, 2022
Polyp, Physician, Medicine, Endoscopic mucosal resection, Partnership, Patient, Hemostasis, Adenoma, Laparoscopy, ESD, Endoscopy, Olympus, Quality of life, News, Multimedia, Safety, EPI, EMR, Pharmaceutical industry, Medical device, GI

WESTBOROUGH, Mass., Dec. 8, 2022 /PRNewswire/ -- Olympus, a global medical technology company focused on designing and delivering innovative solutions for medical and surgical procedures, announced today a new exclusive distribution agreement with EndoClot® Plus, Inc. (EPI) that extends our strategic partnership to the Europe, Middle East and Africa (EMEA) region. This news follows a successful commercialization of the EndoClot product portfolio in the United States, announced in April 2022.

Key Points: 
  • This news follows a successful commercialization of the EndoClot product portfolio in the United States, announced in April 2022.
  • EPI technologies complement Olympus' comprehensive portfolios in GI (gastrointestinal) endoscopy and the company's overall medtech strategy.
  • "We are very excited to expand our global partnership with Olympus," said Stephen Heniges, President, EPI.
  • "With Olympus' support in the U.S. and now EMEA, we expect that more healthcare providers and their patients will be able to benefit from our solutions.

Robo Taxi Market is expected to generate a revenue of USD 38.64 Billion by 2030, Globally, at 67.84% CAGR: Verified Market Research®

Retrieved on: 
Wednesday, December 7, 2022
VMI, Interactivity, Milltown Biomass-to-Energy Power Station, Software, Building & Construction Trades Council v. Associated Builders & Contractors of Massachusetts/Rhode Island, Inc., Oncology, Information, Information and communications technology, System, Transport, Key, R, Defense, Wilderman Medical Clinic, Research, Mineral, SME, Automotive industry, Medical device, Data collection, 7th Sky Entertainment, Education, Geography, Battlefield Extraction-Assist Robot, Component, Metal, Market research, Energy, Neurology, Rancho Los Amigos National Rehabilitation Center, Sofie (surgical robot), New product development, Hospital, Laparoscopy, Orthopedic surgery, Chemical substance, Mining, Medication, Health care, Microsoft Excel

JERSEY CITY, N.J., Dec. 7, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Robo Taxi Market" By Type (L4 robo-taxi, L5 robo-taxi), By Application (Passenger, Freight), and By Geography.

Key Points: 
  • VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market.
  • VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.
  • Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers.
  • Verified Market Research provides advanced analytical research solutions while offering information enriched research studies.

Robo Taxi Market is expected to generate a revenue of USD 38.64 Billion by 2030, Globally, at 67.84% CAGR: Verified Market Research®

Retrieved on: 
Wednesday, December 7, 2022
VMI, Interactivity, Milltown Biomass-to-Energy Power Station, Software, Building & Construction Trades Council v. Associated Builders & Contractors of Massachusetts/Rhode Island, Inc., Oncology, Information, Information and communications technology, System, Transport, Key, R, Defense, Wilderman Medical Clinic, Research, Mineral, SME, Automotive industry, Medical device, Data collection, 7th Sky Entertainment, Education, Geography, Battlefield Extraction-Assist Robot, Component, Metal, Market research, Energy, Neurology, Rancho Los Amigos National Rehabilitation Center, Sofie (surgical robot), New product development, Hospital, Laparoscopy, Orthopedic surgery, Chemical substance, Mining, Medication, Health care, Microsoft Excel

JERSEY CITY, N.J., Dec. 7, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Robo Taxi Market" By Type (L4 robo-taxi, L5 robo-taxi), By Application (Passenger, Freight), and By Geography.

Key Points: 
  • VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market.
  • VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.
  • Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers.
  • Verified Market Research provides advanced analytical research solutions while offering information enriched research studies.